CryoLife's VP-Clinical Research just cashed-in 25,000 options

Scott B Capps, CryoLife's VP-Clinical Research, recently cashed-in 25,000 options. The options were exercised at $9.06, while the sales took place at $10.60 per share, on November 27, 2013. Capps continues to hold 68,303 shares of the company. Capps operates out of Kennesaw, GA. Some additional info was provided as follows:

Reflects weighted average price. Range of prices were between $10.51 and $10.72. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Stock option vests in 1/3 increments beginning on first anniversary of grant date (which was August 2, 2007).

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever CryoLife makes a similar move, sign up!

Other recent filings from the company include the following:

Cryolife Second Quarter 2014 Revenues Increase 3 Percent To A Record - July 24, 2014
CryoLife Just Filed Its Quarterly Report: 15.  Income Per C... - July 24, 2014

   Auto Refresh

Feedback